Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and Equipment
26 Fevereiro 2008 - 12:30PM
PR Newswire (US)
LAKE FOREST, Ill., Feb. 26 /PRNewswire-FirstCall/ -- Hospira, Inc.
(NYSE:HSP), a leading global hospital products company, today
announced a new national agreement with HealthTrust Purchasing
Group, LP (HealthTrust). The multi-year contract will provide
HealthTrust member organizations with access, on a non-exclusive
basis, to Hospira's general-purpose medication infusion devices,
related sets and disposables, along with intravenous (I.V.)
solutions, nutritionals and drug-delivery products. Through
existing agreements, Hospira already provides pain-management
infusion pumps to HealthTrust members, and infusion devices, I.V.
solutions and equipment to members of Consorta -- a group
purchasing organization (GPO) that joined HealthTrust in 2007.
"Hospira's products and services can help HealthTrust's members
meet their goals -- from increasing patient safety to reducing
costs and improving caregiver productivity," said Pete Baker, vice
president and general manager, Commercial Service Operations,
Hospira. "We look forward to developing strong relationships with
HealthTrust's member healthcare institutions." The new agreement
includes Hospira's general-purpose medication infusion
technologies, such as the Plum A+(R) and next-generation Symbiq(R)
infusion systems with Hospira MedNet(R) safety software. These
products play a critical role in improving patient safety as well
as enhancing quality of care and clinician workflow. The contract
also provides access to Hospira's I.V. solutions and associated
equipment portfolio, including the company's more environmentally
preferable VisIV(R) container for I.V. solutions. This contract
represents the first opportunity for Hospira to provide access to
these products to HealthTrust members. About HealthTrust
HealthTrust Purchasing Group, headquartered in Brentwood,
Tennessee, is a group purchasing organization that supports over
3800 not-for-profit and for-profit facilities, which include acute
care hospitals, ambulatory surgery centers, physician practices,
and alternate care sites. With an annual purchasing volume by its
members of more than $13 billion, HealthTrust is committed to
obtaining the best price for clinically-recommended products,
ensuring their timely delivery and continuously evaluating and
improving its services to the patients, physicians and clinicians
it serves. HealthTrust is located at 155 Franklin Road, Suite 400,
Brentwood, TN 37027 Website: http://www.healthtrustpg.com/. About
Hospira Hospira, Inc. is a global specialty pharmaceutical and
medication delivery company dedicated to Advancing Wellness(TM). As
the world leader in specialty generic injectable pharmaceuticals,
Hospira offers one of the broadest portfolios of generic acute-care
and oncology injectables, as well as integrated infusion therapy
and medication management solutions. Through its products, Hospira
helps improve the safety, cost and productivity of patient care.
The company is headquartered in Lake Forest, Ill., and has more
than 14,000 employees. Learn more at http://www.hospira.com/.
Private Securities Litigation Reform Act of 1995 -- A Caution
Concerning Forward-Looking Statements This press release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Hospira cautions that
these forward-looking statements are subject to risks and
uncertainties that may cause actual results to differ materially
from those indicated in the forward-looking statements. Economic,
competitive, governmental, technological and other factors that may
affect Hospira's operations and may cause actual results to be
materially different from expectations include the risks and
uncertainties set forth under the heading "Item 1 Business -- Risk
Factors" in Hospira's Annual Report on Form 10-K for the year ended
Dec. 31, 2006, filed with the Securities and Exchange Commission,
which are incorporated by reference. Hospira undertakes no
obligation to release publicly any revisions to forward-looking
statements as the result of subsequent events or developments.
http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO
http://photoarchive.ap.org/ DATASOURCE: Hospira, Inc. CONTACT:
Media, Jason Hodges, +1-224-212-2863, or Financial Community, Lynn
McHugh, +1-224-212-2363, both of Hospira, Inc. Web site:
http://www.hospira.com/ http://www.healthtrustpg.com/
Copyright
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024